Xilio Therapeutics XLO SEC Filings

NASDAQ XLO
$8.99 +0.02 (+0.28%)
As of: Sep 10, 2026 · 1:21 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Xilio Therapeutics, Inc. (XLO) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index